The NSABP Study of Tamoxifen and Raloxifene (STAR) trial (vol 9, pg 51, 2009)

被引：0
|
作者：
Vogel, Victor G.
机构：
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2009年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：388 / 388
页数：1
相关论文
共 50 条
  • [1] The NSABP Study of Tamoxifen and Raloxifene (STAR) trial
    Vogel, Victor G.
    [J]. Expert Review of Anticancer Therapy, 2009, 9 (01) : 51 - 60
  • [2] Factors associated with participant adherence in the NSABP Study of Tamoxifen and Raloxifene (STAR)
    Cronin, W. M.
    Cecchini, R. S.
    Wickerham, D. L.
    Vogel, V. G.
    Costantino, J. P.
    Wolmark, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial (vol 295, pg 2727, 2006)
    Vogel, V. G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (09): : 973 - 973
  • [4] Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial (vol 295, pg 2727, 2006)
    Vogel, V. G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24): : 2926 - 2926
  • [5] The effects of tamoxifen versus raloxifene on the risk of developing noninvasive breast cancer in the NSABP study of tamoxifen and raloxifene (STAR) P-2 trial.
    Vogel, V. G.
    Costantino, J. P.
    Wickerham, D. L.
    Wolmark, N.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S16 - S16
  • [6] Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial (vol 295, pg 2742, 2006)
    Land, S. R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (09): : 973 - 973
  • [7] Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)
    Runowicz, Carolyn D.
    Costantino, Joseph P.
    Wickerham, Lawrence
    Cecchini, Reena S.
    Cronin, Walter M.
    Ford, Leslie G.
    Vogel, Victor G.
    Wolmark, Norman
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (06) : 535.e1 - 535.e5
  • [8] Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial
    Vogel, Victor G.
    Costantino, Joseph P.
    Wickerham, D. Lawrence
    Cronin, Walter M.
    Cecchini, Reena S.
    Atkins, James N.
    Bevers, Therese B.
    Fehrenbacher, Louis
    Pajon, Eduardo R., Jr.
    Wade, James L., III
    Robidoux, Andre
    Margolese, Richard G.
    James, Joan
    Lippman, Scott M.
    Runowicz, Carolyn D.
    Ganz, Patricia A.
    Reis, Steven E.
    McCaskill-Stevens, Worta
    Ford, Leslie G.
    Jordan, V. Craig
    Wolmark, Norman
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (23): : 2727 - 2741
  • [9] Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial
    Land, Stephanie R.
    Wickerham, D. Lawrence
    Costantino, Joseph P.
    Ritter, Marcie W.
    Vogel, Victor G.
    Lee, Myoungkeun
    Pajon, Eduardo R.
    Wade, James L., III
    Dakhil, Shaker
    Lockhart, James B., Jr.
    Wolmark, Norman
    Ganz, Patricia A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (23): : 2742 - 2751
  • [10] The study of tamoxifen and raloxifene (STAR): Initial findings from the NSABP P-2 breast cancer prevention study.
    Wickerham, D. L.
    Costantino, J. P.
    Vogel, V.
    Cronin, W.
    Cecchini, R.
    Atkins, J.
    Bevers, T.
    Fehrenbacher, L.
    Mccaskill-Stevens, W.
    Wolmark, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2S - 2S
12345